More results concerning Liz Parrish, this is the important part:
No negative effects have been reported, and there are no visible detrimental effects in blood analysis thus far; providing tentative evidence of safety in the first human test of BioViva’s dual gene therapy strategy.
Biomarker analysis and MRI imaging data from the past year have revealed beneficial metabolic changes and muscle improvement in Elizabeth Parrish, CEO of BioViva USA Inc. and recipient of BioViva’s experimental dual gene therapy in September 2015.
In Brief
BMI implant leveraging AI.
You probably clicked on this article because the idea of using brain implants to allow artificial intelligence (AI) to read your brain sounds futuristic and fascinating. It is fascinating, but it’s not as futuristic as you might think. Before we start talking about brain implants and how to augment the human brain using AI, we need to put some context around human intelligence and why we might want to tinker with it.
We floated the idea before that gene editing techniques could allow us to promote genetic intelligence by performing gene editing at the germline. That’s one approach. As controversial as it might be, some solid scientific research shows that genetics does play a role in intelligence. For those of us who are already alive and well, this sort of intelligence enhancement won’t work. This is where we might look towards augmented intelligence. This sort of augmentation of the brain will firstly be preventative in that it will look to assist those who have age associated brain disorders as an example. In order for augmented intelligence to be feasible though, we need a read/write interface to the human brain. One company called Kernel might be looking to address this with a technology that takes a page out of science fiction.
Summary: Researchers have discovered a link between nerve clusters in the brain and the amount of force generated by a physical action.
Source: Oxford University.
Researchers have found a link between the activity in nerve clusters in the brain and the amount of force generated in a physical action, opening the way for the development of better devices to assist paralysed patients.
What generates voltage when you warm it up, push on it, or blow on it?
Get your mind out of the gutter. The correct answer is polyvinylidene fluoride, a material NASA researchers have refined for use in morphing aircraft that shapeshift in response to their environment. But wait! There’s more: It can also kickstart the human body’s healing process.
Because of its potential to heal the world and make it a better place, the polymer’s inventors, Mia Siochi and Lisa Scott Carnell, have now turned it over to the public through NASA’s Technology Transfer Program. Through that process, companies license NASA technology for cheap and turn it into products to sell to non-astronauts. But transforming space stuff into Earth stuff isn’t always smooth. Turned-over technology can get lost inside the catalog, stall out in the bowels of a company, or become part of a product the original inventors wouldn’t approve of.
Our DNA encodes a complex biological blueprint for our lives.
Every toenail, artery, and brain cell we grow is meticulously planned and executed through our DNA’s unfathomably complex genetic instructions.
Recent genetics research has focused on how DNA may affect a person’s education, a field known as ‘educational genomics’.
Bioprinting has been all over the news in the past several years with headline-worthy breakthroughs like printed human skin, synthetic bones, and even a fully functional mouse thyroid gland.
3D printing paved the way for bioprinting thanks to the printers’ unique ability to recreate human tissue structures; their software can be written to ‘stack’ cells in precise patterns as directed by a digital model, and they can produce tissue in just hours and make numerous identical samples.
Despite the progress in bioprinting, however, more complex human organs continue to elude scientists, and resting near the top of the ‘more complex’ list are the kidneys.
More progress to help stroke victims.
Researchers at The University of Manchester have discovered that a potential new drug reduces the number of brain cells destroyed by stroke and then helps to repair the damage.
A reduction in blood flow to the brain caused by stroke is a major cause of death and disability, and there are few effective treatments.
A team of scientists at The University of Manchester has now found that a potential new stroke drug not only works in rodents by limiting the death of existing brain cells but also by promoting the birth of new neurones (so-called neurogenesis).